The pharma industry is on the verge of translating their wearables data into long-term and impactful approaches solutions to improve health.
Pfizer and the Roche Group claim the #1 and #2 positions for leading the way in redefining their value to HCPs March 30, 2016 01:26 AM Eastern Daylight Time […]
Gains full-rights to Padlock’s Protein/Peptidyl Arginine Deiminase (PAD) inhibitor discovery program Expands Bristol-Myers Squibb’s immunoscience pipeline with potentially transformational approach to treating rheumatoid arthritis and other autoimmune diseases March […]
Topas Therapeutics GmbH is based on a proprietary nanoparticle platform which supports antigen-specific tolerance induction for multiple indications Strong consortium consisting of Epidarex Capital, EMBL Ventures, Gimv and Evotec AG […]
Much has been written about the impact of digital media on the life sciences industry. However, an area less discussed is how to maximize that impact globally, and in particular how to organize for success.
Newport Beach, CA — March 15, 2016 Glutenase for in-vivo gluten degradation is a leading candidate for celiac disease ImmunogenX™, a biopharmaceutical company focused on the diagnosis and treatment […]
Johnson & Johnson (JNJ.N) was ordered by a Missouri state jury to pay $72 million of damages to the family of a woman whose death from ovarian cancer was linked […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pronutria Biosciences Inc., a biotechnology company pioneering first-in-class medicines for serious conditions linked to amino acid imbalances, announced today that it has completed a $42.5 million investment by […]
The pharma industry’s R&D concentration has been shifting towards specialty therapy areas as research and development returns decline for some leaders.
Daggerwing Group Inc. announces a move of the company’s New York operations from 250 Greenwich Street to the heart of SoHo at 536 Broadway.
